Article
Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.
The Journal of biological chemistry - 24 Feb 2017
Arkadash Valeria, Yosef Gal, Shirian Jason, Cohen Itay, Horev Yuval, Grossman Moran, Sagi Irit, Radisky Evette S, Shifman Julia M, Papo Niv
Abstract excerpt
Degradation of the extracellular matrices in the human body is controlled by matrix metalloproteinases (MMPs), a family of more than 20 homologous enzymes. Imbalance in MMP activity can result in many diseases, such as arthritis, cardiovascular diseases, neurological disorders, fibrosis, and cancers. Thus, MMPs present attractive targets for drug design and have been a focus for inhibitor design for as long as 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
